Prodotti della ricerca

 
Titolo: Treatment of chronic hepatitis C in patients with glucose-6-phosphate dehydrogenase deficiency: is ribavirin harmful?
Autori: 
Data di pubblicazione: 2006
Rivista: 
BLOOD  
Abstract: Treatment for chronic hepatitis C is based on combination therapy with pegylated interferon and ribavirin (RBV).1,2 One of the most important side effects of RBV is hemolytic anemia, which may require RBV dose reduction or discontinuation3 with a significant decrease in the rate of sustained virologic response (SVR).4 Little is known about the safety of RBV treatment in patients with concomitant glucose-6-phosphate dehydrogenase (G6PD) deficiency, who are inherently prone to hemolysis.5
Handle: http://hdl.handle.net/11584/100128
Tipologia:1.1 Articolo in rivista

File in questo prodotto:
Non ci sono file associati a questo prodotto.
credits unica.it | accessibilità Università degli Studi di Cagliari
C.F.: 80019600925 - P.I.: 00443370929
note legali | privacy

Nascondi la toolbar